분석과학 (Analytical Science and Technology)

  • 제30권3호
  • /
  • Pages.122-129
  • /
  • 2017
  • /
  • 1225-0163(pISSN)
  • /
  • 2288-8985(eISSN)
한국분석과학회 (The Korean Society of Analytical Sciences)
권호 표지
DOI QR코드

DOI QR Code

Comparative analysis of urinary metabolites in methamphetamine self-administrated rats

  • 투고 : 2017.03.07
  • 심사 : 2017.05.04
  • 발행 : 2017.06.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Methamphetamine addiction is a critical issue due to the lack of effective pharmacotherapy and high potential for relapse. Nevertheless, there are no distinct biomarkers for diagnosis or prognosis for methamphetamine addiction. In the present study, a rat model for methamphetamine self-administration was established and alteration of urinary metabolites by methamphetamine addiction was investigated by the targeted metabolite analysis using mass spectrometry. Rat urine samples were collected at three time points (before and after addiction and after extinction) from the methamphetamine-addicted group as well as the age-matched control group. The collected samples were prepared using AbsoluteIDQ p180 kit and analyzed using flow injection analysis (FIA) - or high performance liquid chromatography (HPLC) - tandem mass spectrometry (MS/MS). The levels of lysine, acetylornithine and methioninesulfoxide were distinctively altered depending on the status of metheamphetamine addiction or extinction. In particular, the level of acetylornithine was reversely changed from addiction to extinction, for which further studies could be useful for biomarker discovery or mechanistic studies for methamphetamine addiction.

키워드

참고문헌

  1. W. J. Panenka, R. M. Procyshyn, T. Lecomte, G. W. MacEwan, S. W. Flynn, W. G. Honer, and A. M. Barr, Drug Alcohol Depend, 129(3), 167-79 (2013). https://doi.org/10.1016/j.drugalcdep.2012.11.016
  2. M. Bagheri, A. Mokri, A. Khosravi, and K. Kabir, Int. J. High Risk. Behav. Addict., 4(3), e23903 (2015).
  3. N. Galbraith, BJPsych. Bull., 39(5), 218-20 (2015). https://doi.org/10.1192/pb.bp.115.050930
  4. T. Brackins, N. C. Brahm, and J. C. Kissack, J. Pharm. Pract., 24(6), 541-50 (2011). https://doi.org/10.1177/0897190011426557
  5. H. Li, Q. Bu, B. Chen, X. Shao, Z. Hu, P. Deng, L. Lv, Y. Deng, R. Zhu, Y. Li, B. Zhang, J. Hou, C. Du, Q. Zhao, D. Fu, Y. Zhao, and X. Cen, PLoS One, 9(1), e87040 (2014). https://doi.org/10.1371/journal.pone.0087040
  6. K. J. Boudonck, M. W. Mitchell, L. Nemet, L. Keresztes, A. Nyska, D. Shinar, and M. Rosenstock, Toxicol Pathol, 37(3), 280-92 (2009). https://doi.org/10.1177/0192623309332992
  7. K. Dettmer, P. A. Aronov, and B. D. Hammock, Mass. Spectrom Rev., 26(1), 51-78 (2007). https://doi.org/10.1002/mas.20108
  8. L. V. Panlilio, C. W. Schindler, and S. R. Goldberg, In 'Addiction Research Methods', pp 269-284, Wiley-Blackwell, 2010.
  9. L. V. Panlilio and S. R. Goldberg, Addiction, 102(12), 1863-70 (2007). https://doi.org/10.1111/j.1360-0443.2007.02011.x
  10. H. M. Ahsan, J. B. de la Pena, C. J. Botanas, H. J. Kim, G. Y. Yu, and J. H. Cheong, Biomol. Ther (Seoul), 22(5), 460-6 (2014). https://doi.org/10.4062/biomolther.2014.056
  11. S. S. Yoon, J. W. Seo, S. H. Ann, H. Y. Kim, H. S. Kim, H. Y. Cho, J. Yun, E. Y. Chung, J. S. Koo, and C. H. Yang, Neurosci. Lett., 555, 198-202 (2013). https://doi.org/10.1016/j.neulet.2013.09.029
  12. S. S. Yoon, H. Kim, K. H. Choi, B. H. Lee, Y. K. Lee, S. C. Lim, S. H. Choi, M. Hwang, K. J. Kim, and C. H. Yang, Brain. Res. Bull., 81(6), 625-30 (2010). https://doi.org/10.1016/j.brainresbull.2009.12.011
  13. S. S. Yoon, E. J. Yang, B. H. Lee, E. Y. Jang, H. Y. Kim, S. M. Choi, S. C. Steffensen, and C. H. Yang, Psychopharmacology (Berl), 222(2), 303-11 (2012). https://doi.org/10.1007/s00213-012-2683-3
  14. R. R. Comelia, B.; Sascha, D., 'Analysis of human urine using the AbsoluteIDQTM kit', Biocrates Life Scicences AG.
  15. S. Bouatra, F. Aziat, R. Mandal, A. C. Guo, M. R. Wilson, C. Knox, T. C. Bjorndahl, R. Krishnamurthy, F. Saleem, P. Liu, Z. T. Dame, J. Poelzer, J. Huynh, F. S. Yallou, N. Psychogios, E. Dong, R. Bogumil, C. Roehring, and D. S. Wishart, PLoS One, 8(9), e73076 (2013). https://doi.org/10.1371/journal.pone.0073076
  16. D. S. Wishart, T. Jewison, A. C. Guo, M. Wilson, C. Knox, Y. Liu, Y. Djoumbou, R. Mandal, F. Aziat, E. Dong, S. Bouatra, I. Sinelnikov, D. Arndt, J. Xia, P. Liu, F. Yallou, T. Bjorndahl, R. Perez-Pineiro, R. Eisner, F. Allen, V. Neveu, R. Greiner, and A. Scalbert, Nucleic. Acids. Res., 41(Database issue), D801-7 (2013). https://doi.org/10.1093/nar/gks1065
  17. K. Suhre, S. Y. Shin, A. K. Petersen, R. P. Mohney, D. Meredith, B. Wagele, E. Altmaier, CardioGram, P. Deloukas, J. Erdmann, E. Grundberg, C. J. Hammond, M. H. de Angelis, G. Kastenmuller, A. Kottgen, F. Kronenberg, M. Mangino, C. Meisinger, T. Meitinger, H. W. Mewes, M. V. Milburn, C. Prehn, J. Raffler, J. S. Ried, W. Romisch-Margl, N. J. Samani, K. S. Small, H. E. Wichmann, G. Zhai, T. Illig, T. D. Spector, J. Adamski, N. Soranzo, and C. Gieger, Nature, 477(7362), 54-60 (2011). https://doi.org/10.1038/nature10354
  18. B. Yu, Y. Zheng, D. Alexander, A. C. Morrison, J. Coresh, and E. Boerwinkle, PLoS Genet, 10(3), e1004212 (2014). https://doi.org/10.1371/journal.pgen.1004212
  19. J. L. McClay, S. A. Vunck, A. M. Batman, J. J. Crowley, R. E. Vann, P. M. Beardsley, and E. J. van den Oord, J Neuroimmune Pharmacol, 10(3), 425-34 (2015). https://doi.org/10.1007/s11481-015-9605-1